<?xml version="1.0" encoding="UTF-8"  standalone="no" ?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="2008-10-14" modified="2023-09-13" version="22" xmlns="http://uniprot.org/uniprot">
  <accession>P86013</accession>
  <accession>M1FLQ2</accession>
  <name>LANPA_PAEPO</name>
  <protein>
    <recommendedName>
      <fullName evidence="5">Lantibiotic paenibacillin</fullName>
    </recommendedName>
  </protein>
  <gene>
    <name evidence="7" type="primary">paenA</name>
  </gene>
  <organism>
    <name type="scientific">Paenibacillus polymyxa</name>
    <name type="common">Bacillus polymyxa</name>
    <dbReference type="NCBI Taxonomy" id="1406"/>
    <lineage>
      <taxon>Bacteria</taxon>
      <taxon>Bacillota</taxon>
      <taxon>Bacilli</taxon>
      <taxon>Bacillales</taxon>
      <taxon>Paenibacillaceae</taxon>
      <taxon>Paenibacillus</taxon>
    </lineage>
  </organism>
  <reference key="1">
    <citation type="submission" date="2012-02" db="EMBL/GenBank/DDBJ databases">
      <title>Biosynthesis of the antimicrobial peptide paenibacillin in Paenibacillus polymyxa OSY-DF.</title>
      <authorList>
        <person name="Huang E."/>
        <person name="Yousef A.E."/>
      </authorList>
    </citation>
    <scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
    <source>
      <strain>OSY-DF</strain>
    </source>
  </reference>
  <reference evidence="6" key="2">
    <citation type="journal article" date="2007" name="Appl. Environ. Microbiol." volume="73" first="168" last="178">
      <title>Isolation and identification of a Paenibacillus polymyxa strain that coproduces a novel lantibiotic and polymyxin.</title>
      <authorList>
        <person name="He Z."/>
        <person name="Kisla D."/>
        <person name="Zhang L."/>
        <person name="Yuan C."/>
        <person name="Green-Church K.B."/>
        <person name="Yousef A.E."/>
      </authorList>
      <dbReference type="PubMed" id="17071789"/>
      <dbReference type="DOI" id="10.1128/aem.02023-06"/>
    </citation>
    <scope>PROTEIN SEQUENCE</scope>
    <scope>FUNCTION</scope>
    <scope>SUBCELLULAR LOCATION</scope>
    <scope>POST-TRANSLATIONAL MODIFICATIONS</scope>
    <scope>MASS SPECTROMETRY</scope>
    <source>
      <strain evidence="2">OSY-DF</strain>
    </source>
  </reference>
  <reference key="3">
    <citation type="journal article" date="2008" name="FEBS Lett." volume="582" first="2787" last="2792">
      <title>N-terminal acetylation in paenibacillin, a novel lantibiotic.</title>
      <authorList>
        <person name="He Z."/>
        <person name="Yuan C."/>
        <person name="Zhang L."/>
        <person name="Yousef A.E."/>
      </authorList>
      <dbReference type="PubMed" id="18625234"/>
      <dbReference type="DOI" id="10.1016/j.febslet.2008.07.008"/>
    </citation>
    <scope>SUBCELLULAR LOCATION</scope>
    <scope>MASS SPECTROMETRY</scope>
    <scope>STRUCTURE BY NMR OF 24-53</scope>
    <scope>ACETYLATION AT ALA-24</scope>
    <scope>DEHYDRATION AT SER-25; THR-29; THR-30 AND SER-50</scope>
    <scope>LANTHIONINE CROSS-LINKS</scope>
    <source>
      <strain evidence="3">OSY-DF</strain>
    </source>
  </reference>
  <comment type="function">
    <text evidence="2">Lanthionine-containing peptide antibiotic (lantibiotic) active on Gram-positive bacteria. The bactericidal activity of lantibiotics is based on depolarization of energized bacterial cytoplasmic membranes, initiated by the formation of aqueous transmembrane pores. Lacks antibacterial activity against Gram-negative bacteria.</text>
  </comment>
  <comment type="subcellular location">
    <subcellularLocation>
      <location evidence="2 3">Secreted</location>
    </subcellularLocation>
  </comment>
  <comment type="PTM">
    <text evidence="2">Maturation of lantibiotics involves the enzymatic conversion of Thr, and Ser into dehydrated AA and the formation of thioether bonds with cysteine. This is followed by membrane translocation and cleavage of the modified precursor.</text>
  </comment>
  <comment type="PTM">
    <text>The structure of the 2,3-didehydrobutyrines is not discussed in PubMed:17071789.</text>
  </comment>
  <comment type="mass spectrometry" mass="2983.54" method="MALDI" evidence="2 3"/>
  <comment type="mass spectrometry" mass="2983.44" method="Electrospray" evidence="2 3"/>
  <comment type="mass spectrometry" mass="2984.61" method="MALDI" evidence="2 3"/>
  <comment type="similarity">
    <text evidence="1">Belongs to the type A lantibiotic family.</text>
  </comment>
  <dbReference type="EMBL" id="JQ728481">
    <property type="protein sequence ID" value="AFS60100.1"/>
    <property type="molecule type" value="Genomic_DNA"/>
  </dbReference>
  <dbReference type="AlphaFoldDB" id="P86013"/>
  <dbReference type="iPTMnet" id="P86013"/>
  <dbReference type="GO" id="GO:0005576">
    <property type="term" value="C:extracellular region"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0005102">
    <property type="term" value="F:signaling receptor binding"/>
    <property type="evidence" value="ECO:0007669"/>
    <property type="project" value="UniProtKB-KW"/>
  </dbReference>
  <dbReference type="GO" id="GO:0051838">
    <property type="term" value="P:cytolysis by host of symbiont cells"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0050830">
    <property type="term" value="P:defense response to Gram-positive bacterium"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="NCBIfam" id="NF038155">
    <property type="entry name" value="lanthi_I_FDLD"/>
    <property type="match status" value="1"/>
  </dbReference>
  <proteinExistence type="evidence at protein level"/>
  <keyword id="KW-0007">Acetylation</keyword>
  <keyword id="KW-0044">Antibiotic</keyword>
  <keyword id="KW-0929">Antimicrobial</keyword>
  <keyword id="KW-0078">Bacteriocin</keyword>
  <keyword id="KW-0903">Direct protein sequencing</keyword>
  <keyword id="KW-0425">Lantibiotic</keyword>
  <keyword id="KW-0964">Secreted</keyword>
  <keyword id="KW-0883">Thioether bond</keyword>
  <feature type="propeptide" id="PRO_0000450323" evidence="4">
    <location>
      <begin position="1"/>
      <end position="24"/>
    </location>
  </feature>
  <feature type="peptide" id="PRO_0000352649" description="Lantibiotic paenibacillin" evidence="2">
    <location>
      <begin position="24"/>
      <end position="53"/>
    </location>
  </feature>
  <feature type="modified residue" description="N-acetylalanine" evidence="3">
    <location>
      <position position="24"/>
    </location>
  </feature>
  <feature type="modified residue" description="2,3-didehydroalanine (Ser)" evidence="3">
    <location>
      <position position="25"/>
    </location>
  </feature>
  <feature type="modified residue" description="2,3-didehydrobutyrine" evidence="3">
    <location>
      <position position="29"/>
    </location>
  </feature>
  <feature type="modified residue" description="2,3-didehydrobutyrine" evidence="3">
    <location>
      <position position="30"/>
    </location>
  </feature>
  <feature type="modified residue" description="2,3-didehydroalanine (Ser)" evidence="3">
    <location>
      <position position="50"/>
    </location>
  </feature>
  <feature type="cross-link" description="Lanthionine (Ser-Cys)" evidence="3">
    <location>
      <begin position="34"/>
      <end position="38"/>
    </location>
  </feature>
  <feature type="cross-link" description="Beta-methyllanthionine (Thr-Cys)" evidence="3">
    <location>
      <begin position="40"/>
      <end position="43"/>
    </location>
  </feature>
  <feature type="cross-link" description="Beta-methyllanthionine (Thr-Cys)" evidence="3">
    <location>
      <begin position="42"/>
      <end position="45"/>
    </location>
  </feature>
  <feature type="cross-link" description="Beta-methyllanthionine (Thr-Cys)" evidence="3">
    <location>
      <begin position="46"/>
      <end position="49"/>
    </location>
  </feature>
  <feature type="cross-link" description="Lanthionine (Ser-Cys)" evidence="3">
    <location>
      <begin position="48"/>
      <end position="52"/>
    </location>
  </feature>
  <evidence type="ECO:0000255" key="1"/>
  <evidence type="ECO:0000269" key="2">
    <source>
      <dbReference type="PubMed" id="17071789"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="3">
    <source>
      <dbReference type="PubMed" id="18625234"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="4">
    <source ref="1"/>
  </evidence>
  <evidence type="ECO:0000303" key="5">
    <source>
      <dbReference type="PubMed" id="17071789"/>
    </source>
  </evidence>
  <evidence type="ECO:0000305" key="6"/>
  <evidence type="ECO:0000312" key="7">
    <source>
      <dbReference type="EMBL" id="AFS60100.1"/>
    </source>
  </evidence>
  <sequence length="53" mass="5819" checksum="DC8BCD3C2E52580C" modified="2020-06-17" version="2" precursor="true">MKVDQMFDLDLRKSYEASELSPQASIIKTTIKVSKAVCKTLTCICTGSCSNCK</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>